An in-depth guide to physical therapy valuation multiples, including buyer-accepted EBITDA, clinic density, referral and payer mix, clinician productivity, platform quality, diligence risk, and seller proceeds.
An in-depth guide to physical therapy practice valuation, including buyer-accepted EBITDA, clinic-level economics, payer and referral risk, valuation methods, and the bridge from enterprise value to seller proceeds.
A buyer-underwriting guide to fertility clinic valuation, including IVF cycle volume, patient and payer mix, physician and embryology capacity, lab economics, reported-to-normalized-to-buyer-accepted EBITDA, free cash flow, valuation methods and multiple logic, ownership and transferability, enterprise value, equity value, diligence repricing, financing constraints, and seller proceeds.
A transaction-focused guide to personal care agency valuation, connecting operating evidence, buyer underwriting, transaction risk, and seller outcomes.
By George Barsom, JD, CM&AA®, CAIA® • Last updated: July 12, 2026 Updated for ambulatory surgery center owners, physician investors, health systems, strategic operators, private equity sponsors, lenders, attorneys, accountants, and transaction professionals evaluating ASC fair market value, normalized EBITDA, case economics, ownership interests, real estate, risk, transaction structure, and seller proceeds. Key answer: an ambulatory surgery…
A buyer-focused guide to urgent care valuation multiples, including EBITDA and revenue benchmarks, earnings scale, clinic profiles, payer economics, provider staffing, site performance, platform versus add-on pricing, financing, sensitivity, deal structure, and seller proceeds.
A transaction-focused guide to medical practice valuation, including normalized EBITDA adjustments, specialty-specific risk, multiple selection, buyer diligence priorities, and a worked bridge from enterprise value to realistic seller proceeds.
By George Barsom, JD, CM&AA®, CAIA® • Last updated: June 8, 2026 Updated for physician practice owners evaluating EBITDA multiples, revenue multiples, specialty mix, adjusted EBITDA, payer mix, referral durability, provider dependence, buyer demand, diligence risk, deal structure, and seller proceeds. This guide focuses on how buyers interpret multiples in actual transaction underwriting and why similar practices…